BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Diagnosis
13 results:

  • 1. Treatment of Nevus of Ota in Black patients with the 1064 nm QS or picosecond laser and nonablative fractional photothermolysis.
    Kubicki SL; Guo EL; Richmond H; Friedman PM
    Lasers Surg Med; 2023 Jan; 55(1):67-72. PubMed ID: 36124432
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy of a Deep Learning Convolutional Neural Network System for Melanoma diagnosis in a Hospital Population.
    Martin-Gonzalez M; Azcarraga C; Martin-Gil A; Carpena-Torres C; Jaen P
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409575
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Assessment of deep neural networks for the diagnosis of benign and malignant skin neoplasms in comparison with dermatologists: A retrospective validation study.
    Han SS; Moon IJ; Kim SH; Na JI; Kim MS; Park GH; Park I; Kim K; Lim W; Lee JH; Chang SE
    PLoS Med; 2020 Nov; 17(11):e1003381. PubMed ID: 33237903
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
    Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
    J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Usefulness of neuron-specific enolase as a serum marker of metastatic melanoma.
    Sato S; Kato J; Sawada M; Horimoto K; Okura M; Hida T; Uhara H
    J Dermatol; 2020 Oct; 47(10):1141-1148. PubMed ID: 32734632
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Validation of an integrated dermoscopic scoring method in an European teledermoscopy web platform: the iDScore project for early detection of melanoma.
    Tognetti L; Cevenini G; Moscarella E; Cinotti E; Farnetani F; Lallas A; Tiodorovic D; Carrera C; Puig S; Perrot JL; Longo C; Argenziano G; Pellacani G; Smargiassi E; Cataldo G; Cartocci A; Balistreri A; Rubegni P
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):640-647. PubMed ID: 31465600
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?
    Pitre LD; Linford G; Pond GR; McWhirter E; Seow H
    J Cutan Med Surg; 2019; 23(6):586-594. PubMed ID: 31462069
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid - a population-based analysis.
    Lee IJ; Koh JY
    Orbit; 2019 Aug; 38(4):261-268. PubMed ID: 30373440
    [No Abstract]    [Full Text] [Related]  

  • 9. Fat Intake and Risk of skin cancer in U.S. Adults.
    Park MK; Li WQ; Qureshi AA; Cho E
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):776-782. PubMed ID: 29636341
    [No Abstract]    [Full Text] [Related]  

  • 10. Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).
    Lebbe C; Lorigan P; Ascierto P; Testori A; Bédane C; Middleton M; van Baardewijk M; Konto C; Dueymes A; Maio M
    Eur J Cancer; 2012 Nov; 48(17):3205-14. PubMed ID: 22742880
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Squamous cell carcinoma of the skin induces considerable sustained cost of care in organ transplant recipients.
    Rüegg CP; Graf N; Mühleisen B; Szucs TD; French LE; Surber C; Hofbauer GF
    J Am Acad Dermatol; 2012 Dec; 67(6):1242-9. PubMed ID: 22695101
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [The cost of Mohs micrographic surgery for basal cell carcinoma. The Ambroise Paré hospital's experience (Boulogne, France)].
    Sznajder M; Chaussade V; Zimmermann U; Sei JF; Bendersky N; Franc B; Saiag P
    Ann Dermatol Venereol; 2004 Feb; 131(2):150-6. PubMed ID: 15026741
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens.
    Berger CL; Morrison S; Chu A; Patterson J; Estabrook A; Takezaki S; Sharon J; Warburton D; Irigoyen O; Edelson RL
    J Clin Invest; 1982 Dec; 70(6):1205-15. PubMed ID: 6217214
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.